Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Redhill Biopharma Ltd. (RDHL) had Stock-Based Compensation of $0.23M for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$15.70M |
|
$0.15M |
|
$6.32M |
|
$22.02M |
|
$21.23M |
|
-- |
|
$0.73M |
|
$21.96M |
|
$0.06M |
|
$-5.50M |
|
$0.06M |
|
-- |
|
| Cash Flow Statement Financials | |
$-6.18M |
|
$-0.00M |
|
$7.90M |
|
$5.57M |
|
$7.28M |
|
$1.71M |
|
|
Stock-Based Compensation |
$0.23M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|